Analysis of four SNPs, in tandem with genetic risk factors detected by the deCODE ProstateCancer™ test, yields substantial improvement in efficacy of PSA screening Reykjavik, ICELAND, 15 December 2010 – Scientists from deCODE genetics and academic colleagues from...
